1. EPS3.05 GLPG2222 in subjects with cystic fibrosis homozygous for F508del: results from a phase II study (FLAMINGO);van der Ent;J Cyst Fibros,2018
2. WS01.4 GLPG2222 in subjects with cystic fibrosis and the F508del/class III mutation on stable treatment with ivacaftor: results from a phase II study (ALBATROSS);Bell;J Cyst Fibros,2018
3. Results from a phase II study - ALBATROSS - evaluation of GLPG2222 in subjects with CF and the F508del/classIII mutation on stable treatment with ivacaftor. Abstract 269;Bell;Pediatr Pulmonol,2018
4. GLPG2222 in CF subjects homozygous for F508del: results from a phase II study (FLAMINGO). Abstract 271;van der Ent;Pediatr Pulmonol,2018
5. Cystic fibrosis: current therapeutic targets and future approaches;Rafeeq;J Transl Med,2017